gptkb:Aducanumab
|
NCT02477800
|
gptkb:allogeneic_CAR-T_cells
|
investigational
|
gptkb:ALLO-647
|
Phase 1
|
gptkb:RLY-2608
|
Phase 1
|
gptkb:CAR-T_cell
|
gptkb:Phase_I
|
gptkb:SDHD_gene
|
available for hereditary paraganglioma syndromes
|
gptkb:ROCKET_trial
|
gptkb:NCT00403767
|
gptkb:Novocure
|
EF-14
|
gptkb:NUC-7738
|
Phase I/II
|
gptkb:Viracta_Therapeutics
|
Phase 2 trial for nanatinostat
|
gptkb:MRTX1719
|
Phase 1/2
|
gptkb:MAOA_gene
|
genetic testing for Brunner syndrome
|
gptkb:MLN-T
|
gptkb:Phase_I
|
gptkb:tafolecimab
|
Phase 3
|
gptkb:Bicycle_Therapeutics
|
gptkb:BT1718
|
gptkb:vopratelimab
|
Phase 2
|
gptkb:NCT01035255
|
Phase 2
|
gptkb:CA-170
|
Phase 1
|
gptkb:RG-7112
|
gptkb:Phase_I
|
gptkb:STH-87
|
Phase 2/3
|